drugset / Trial / NCT01589432

A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy

NCT01589432

Phase 2 Completed 39 enrolled AbbVie
RandomizedParallel-groupDouble-blindBasic science

Summary

People with diabetes can, over time develop nerve damage throughout the body with symptoms such as pain, tingling, or numbness (loss of feeling) in the hands, arms, feet and legs.

Timeline

Start
2012-04
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject ABT-639 Small molecule 100 mg Oral
Comparator Lidocaine Other / unclassified 3 mg/kg